Please refer enclosed file
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.1 pts less than Nifty Microcap 250 and 6.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar and Company (Keva) reported consolidated revenue from operations of ₹2,368.26 crore for FY2026, up 11.5% from ₹2,123.40 crore in FY2025. However, profit after tax (owners) declined to ₹69.26 crore from ₹73.24 crore in the prior year, a fall of about 5.4%. Q4 FY2026 was particularly weak with net profit of just ₹1.80 crore, down sharply from ₹102.51 crore in Q4 FY2025. The company recognised a net exceptional gain of ₹35.92 crore, mainly from insurance claim realisations related to the April 2024 Vashivali plant fire. Auditors Deloitte Haskins & Sells LLP issued unmodified opinions on both standalone and consolidated results. The company announced appointment of B S R & Co. LLP as new statutory auditors for 5 years from the 70th AGM, replacing Deloitte. The 70th AGM is scheduled for July 31, 2026.
Revenue growth of 11.5% is positive but PAT declined year-on-year, which may disappoint shareholders. The sharp Q4 profit drop despite higher revenue suggests cost pressures. The auditor change from Deloitte to B S R & Co. LLP is notable but carries no adverse signal as both are major firms.